Immuno-modulation of allergic airway inflammation with replication-deficient adenoviral (RDA) vector as a therapeutic agent

被引：0
|
作者：
Muralidhar, G [1 ]
Pandit, TS [1 ]
Sikora, L [1 ]
Rao, SP [1 ]
Sriramarao, P [1 ]
机构：
[1] La Jolla Inst Mol Med, San Diego, CA 92121 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1448 / A1449
页数：2
相关论文
共 13 条
  • [1] Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation
    Piedimonte, G
    Pickles, RJ
    Lehmann, JR
    McCarty, D
    Costa, DL
    Boucher, RC
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) : 250 - 258
  • [2] Establishment of a Chimeric, Replication-Deficient Influenza A Virus Vector by Modulation of Splicing Efficiency
    Wolschek, Markus
    Samm, Elisabeth
    Seper, Helena
    Sturlan, Sanda
    Kuznetsova, Irina
    Schwager, Cornelia
    Khassidov, Alexandra
    Kittel, Christian
    Muster, Thomas
    Egorov, Andrej
    Bergmann, Michael
    JOURNAL OF VIROLOGY, 2011, 85 (05) : 2469 - 2473
  • [3] In vivo transfer of the human catalase gene to the guinea pig eye mediated by a replication-deficient adenoviral vector
    Qi, X
    Guy, J
    Deshmane, SL
    Crystal, RG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 2969 - 2969
  • [4] Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches
    Murakami, P
    Havenga, M
    Fawaz, F
    Vogels, R
    Marzio, G
    Pungor, E
    Files, J
    Do, L
    Goudsmit, J
    McCaman, M
    JOURNAL OF VIROLOGY, 2004, 78 (12) : 6200 - 6208
  • [5] Suppression of eosinophilic inflammation of the airway following intranasal administration of a replication-deficient adenovirus in mice.
    Suzuki, M
    Komatsu, S
    Yamamoto, N
    Miyashita, A
    Nishikawa, M
    Ikeda, H
    Suzuki, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A433 - A433
  • [6] Evaluating the Toxocara cati extract as a therapeutic agent for allergic airway inflammation
    Bakhshani, Amin
    Shirvan, Sima Parande
    Sadr, Soheil
    Maleki, Mohsen
    Haghparast, Alireza
    Borji, Hassan
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (06)
  • [7] Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
    Folegatti, Pedro M.
    Jenkin, Daniel
    Morris, Susan
    Gilbert, Sarah
    Kim, Denny
    Robertson, James S.
    Smith, Emily R.
    Martin, Emalee
    Gurwith, Marc
    Chen, Robert T.
    VACCINE, 2022, 40 (35) : 5248 - 5262
  • [8] Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice
    Fu, Yuanhui
    He, Jinsheng
    Zheng, Xianxian
    Wu, Qiang
    Zhang, Mei
    Wang, Xiaobo
    Wang, Yan
    Xie, Can
    Tang, Qian
    Wei, Wei
    Wang, Min
    Song, Jingdong
    Qu, Jianguo
    Zhang, Ying
    Wang, Xin
    Hong, Tao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 381 (04) : 528 - 532
  • [9] Transplacental immune modulation with a bacterial-derived agent protects against allergic airway inflammation
    Mincham, Kyle T.
    Scott, Naomi M.
    Lauzon-Joset, Jean-Francois
    Leffler, Jonatan
    Larcombe, Alexander N.
    Stumbles, Philip A.
    Robertson, Sarah A.
    Pasquali, Christian
    Holt, Patrick G.
    Strickland, Deborah H.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (11): : 4856 - 4869
  • [10] Orally administered fisetin as an immuno-modulatory and therapeutic agent in a mouse model of chronic allergic airway disease
    Paul, Pramathadhip
    Majhi, Sourav
    Mitra, Shinjini
    Banerjee, Ena Ray
    BIOMEDICAL RESEARCH AND THERAPY, 2019, 6 (07): : 3262 - 3273
12